Issue Date: October 3, 2016
Cambrex gets PharmaCore
The pharmaceutical chemical maker Cambrex will pay $25 million to acquire PharmaCore, a High Point, N.C.-based developer of small-molecule active pharmaceutical ingredients for clinical trials. PharmaCore has annual sales of $15 million to $17 million and employs nearly 40 chemists, most of whom hold Ph.D.s. Cambrex says the company will complement its large-scale manufacturing facilities in the U.S. and Europe.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society